Solventum Corp. (SOLV)
91.69
-0.75
(-0.81%)
USD |
NYSE |
Sep 04, 16:00
91.69
0.00 (0.00%)
Pre-Market: 20:00
Solventum SG&A Expense (TTM) : 3.293B for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.293B |
| March 31, 2026 | 3.138B |
| December 31, 2025 | 3.08B |
| September 30, 2025 | 3.105B |
| June 30, 2025 | 3.026B |
| March 31, 2025 | 2.955B |
| December 31, 2024 | 2.782B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.998B |
| June 30, 2024 | 1.822B |
| March 31, 2024 | 1.70B |
| December 31, 2023 | 1.681B |
| September 30, 2023 | 1.681B |
| June 30, 2023 | 1.156B |
| March 31, 2023 | 577.00M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Stryker Corp. | 8.782B |
| Zimmer Biomet Holdings, Inc. | 3.433B |
| Edwards Lifesciences Corp. | 2.201B |
| Intuitive Surgical, Inc. | 2.492B |
| Inspire Medical Systems, Inc. | 620.30M |